A high-resolution screening platform, coupling online affinity detection for mammalian cytochrome P450s (Cyt P450s) to gradient reversed-phase high-performance liquid chromatography (HPLC), is described. To this end, the online Cyt P450 enzyme affinity detection (EAD) system was optimized for enzyme (β-NF-induced rat liver microsomes), probe substrate (ethoxyresorufine), and organic modifier (methanol or acetonitrile). The optimized Cyt P450 EAD system has first been evaluated in a flow injection analysis (FIA) mode with 7 known ligands of Cyt P450 1A1/1A2 (α-naphthoflavone, βnaphthoflavone, ellipticine, 9-hydroxy-ellipticine, fluvoxamine, caffein, and phenacetin). Subsequently, IC 50 values were online in FIA-mode determined and compared with those obtained with standard microsomal assay conditions. The IC 50 values obtained with the online Cyt P450 EAD system agreed well with the IC 50 values obtained in the standard assays. For highaffinity ligands of Cyt P450 1A1/1A2, detection limits of 1 to 3 pmol injected (n = 3; signal to noise [S/N] = 3) were obtained. The individual inhibitory properties of ligands in mixtures of the ligands were subsequently investigated using an optimized Cyt P450 EAD system online coupled to gradient HPLC. Using the integrated online gradient HPLC Cyt P450 EAD platform, detection limits of 10 to 25 pmol injected (n = 1; S/N = 3) were obtained for high-affinity ligands. It is concluded that this novel screening technology offers new perspectives for rapid and sensitive screening of individual compounds in mixtures exhibiting affinity for liver microsomal Cyt P450s. (Journal of Biomolecular Screening 2005:427-436) 
INTRODUCTION
C YTOCHROMES P450 (Cyt P450s) constitute the most important group of hepatic biotransformation enzymes involved in the metabolism of drugs and other xenobiotics. [1] [2] [3] Cyt P450s are membrane-bound heme-containing proteins that are expressed in the endoplasmatic reticulum of cells and on the inner membranes of mitochondria. 4 The major Cyt P450s involved in drug metabolism are located in the liver, although they also occur in other organs and tissues. 5 For the catalytic cycling, Cyt P450s depend on the electron-donating capacity of nicotinamide adenine dinucleotide phosphate (NADPH) Cyt P450 reductases. 6 Metabolism of chemical entities by Cyt P450s may have important biological consequences. Bioactivation, resulting in metabolites with enhanced pharmacological or toxicological activities, can occur, whereas the biological activity of parent compounds may also be antagonized by one or more of its active metabolites. Inhibition of Cyt P450s by parent compounds and/or their metabolites may also result in drug-drug interactions. 7 Knowledge of the affinity of new chemical entities and drug candidate compounds to Cyt P450s is therefore generally seen as crucial in drug discovery and development and safety assessment. 7, 8 When many compounds need to be evaluated for Cyt P450 binding, for Cyt P450-mediated turnover, and for drug-drug interactions at the level of Cyt P450s, 9, 10 often in vitro high-throughput screening (HTS) methodologies are used. The method of choice for this type of screening is currently the inhibition of fluorescent metabolite formation from probe substrates in microplate reader screening assays. [11] [12] [13] [14] This approach, however, cannot be applied for the identification of Cyt P450 ligands in mixtures of compounds, as is the case with natural compound extracts, combinatorial chemistry mixtures, and drug metabolite mixtures. In such cases, separation of the mixtures followed by Cyt P450 affinity testing of the individual compounds is needed. Several years ago, a new online high-resolution screening (HRS) concept for the screening of ligands to the estrogen receptor (ERα) was reported. 15 This HRS concept was based on a continuous-flow bioassay, coupled online to high-performance liquid chromatography (HPLC). It circumvented several of the above-mentioned problems by combining the resolving power of HPLC with efficient screening properties of a bioassay. Meanwhile, such HRS assays have been based on soluble receptors, 15, 16 enzymes, 17 and antibodies. 18, 19 Systems based on mass spectrometry, in which compounds are screened for affinity toward several receptors and enzymes in 1 bioassay, also exist. 20, 21 However, no bioaffinity detection systems are yet available for the screening of individual compounds in mixtures for Cyt P450 affinity.
In this article, we describe the design, optimization, and validation of a novel HRS system based on Cyt P450 enzyme affinity detection (Cyt P450 EAD). The novel Cyt P450 EAD system is based on the inhibition of fluorescent product formation by Cyt P450s. 22, 23 The Cyt P450 EAD system is operated by mixing Cyt P450 enzyme, substrate, and cofactor continuously with the eluent of a carrier solution. In a handmade knitted 19, 24 reaction coil, the substrate is converted into a highly fluorescent product. Eluting ligands compete with the substrate for the active site of the Cyt P450 concerned and cause a temporary decrease in fluorescent product formation monitored by fluorescence detection. The Cyt P450 EAD system was first evaluated for individual components in flow injection analysis (FIA) mode and subsequently coupled online to gradient HPLC for online detection of affinities of individual compounds in mixtures to Cyt P450s. When operated in gradient HPLC Cyt P450 EAD mode, the carrier solution of the FIA system is replaced by the eluent of a gradient HPLC system, allowing mixtures of compounds to be separated by HPLC and subsequently detected online with the new Cyt P450 EAD system. The Cyt P450 EAD system in the HPLC mode developed is a valuable new tool to screen individual components in mixtures selectively and sensitively for affinities to Cyt P450s. Because Cyt P450 affinities are potentially related to drug metabolism, drug toxification, and drug-drug interactions, this may be of added value in drug discovery and development and safety assessment.
EXPERIMENTAL SECTION

Materials
Ethoxyresorufin, Tween-20 and Tween-80, L-αphosphatidylcholine-dilauroyl, saponin (from Quillaja bark), glycerol, casein hydrolysate, polyethyleneglycol 6000 (PEG 6000), polyethyleneglycol 3350 (PEG 3350), polyethylenimine (50% aq. solution), and α-naphthoflavone (α-NF) were purchased from Sigma (Zwijndrecht, the Netherlands). Dextran (MW 60-90 kD) was from Duchefa (Haarlem, the Netherlands), caffein and sodium cholate were from Aldrich (Zwijndrecht, the Netherlands), and β-naphthoflavone (β-NF) was from Acros (Den Bosch, the Netherlands). β-NADPH tetra sodium salt was obtained from Applichem (Lokeren, Belgium), enzyme-linked immunosorbent assay (ELISA) blocking reagent was from Hoffmann-La Roche (Mannheim, Germany), bovine serum albumin (BSA) was from Life Technologies (Paisley, UK), and methanol (MeOH) and acetonitrile (MeCN) were purchased from Baker (Deventer, the Netherlands) and were of HPLC reagent grade. All other chemicals were of the highest purity grade commercially available.
Rat liver microsomes (β-NF induced) were prepared as described elsewhere. 25 In short: livers from β-NF-induced rats were homogenized at 4°C in 2 volumes of 50 mM potassium phosphate buffer (pH 7.4) with 0.9% sodium chloride using a Potter-Elvehjem homogenizer. The homogenate was centrifuged for 20 min at 12000g, and the supernatant obtained was further centrifuged for 60 min at 100,000g. The resulting pellet was washed twice and subsequently resuspended in 50 mM potassium phosphate buffer (pH 7.4), 0.9% sodium chloride, and 25% glycerol and stored at -80°C. Protein concentration in the microsomes was determined to be 13.1 mg/mL.
Instrumentation
Two Knauer K-500 HPLC pumps (Berlin, Germany) were used to control the Pharmacia 50-mL superloops (Uppsala, Sweden) containing enzyme (rat liver cytochrome P450s) and cofactor/substrate (NADPH/ethoxyresorufine), respectively, and 1 Knauer K-500 HPLC pump was used for delivery of the injected samples. Both superloops were kept on ice. For proper operation of the pumps at low flow rates (100 µL/min) and for pulse dampening, flow restrictors were inserted directly after the pumps and before the superloops. The flow restrictors, comprising 10 cm length, 25 µm i.d., 375 µm o.d. fused silica connected to a 2-µm frit filter, produced back pressures of approximately 100 bar. The pressure limits of the pumps were set 20 bar higher than the working pressure to prevent damage to the superloops due to possible clogging of the system. Sample injections were performed with a Gilson 234 autoinjector (Villiers-le-Bel, France) equipped with a Rheodyne (Bensheim, Germany) 6-port injection valve (injection loop, 50 µL). An Agilent 1100 (Waldbronn, Germany) series fluorescence detector (λ ex 530 nm; λ em 586 nm) was used for monitoring fluorescence. The temperature of the reaction coil was controlled by a Shimadzu CTO-10AC column oven (Duisburg, Germany). During optimization, the carrier solution was water (100 µL/min). Samples were flow-injected in the carrier solution prior to mixing with buffer solution containing the enzyme (100 µL/min) and the cofactor/substrate solution (100 µL/min). Knitted PTFE reaction coils (0.25 mm i.d.; 0.8 mm o.d.; internal volumes of 25, 50, 75, 100, and 150 µL) were tested for the online enzymatic reaction prior to detection. All hardware was integrated in 1 system by Kiadis B.V. (Groningen, the Netherlands) and was controlled by software developed by Kiadis B.V.
Cyt P450 enzyme affinity detection in flow injection analysis mode
A scheme of the Cyt P450 EAD system in FIA mode is shown in Figure 1A . The Cyt P450 EAD system is operated by mixing Cyt P450 enzymes (liver microsomes from β-NF-induced rats), substrate (ethoxyresorufine), and cofactor (NADPH) continuously with a carrier solution. After mixing in a knitted reaction coil, the substrate ethoxyresorufine is converted in the reaction coil into the highly fluorescent product resorufine. 26 The high expression level of Cyt P450 1A1/1A2 in β-NF-induced rat liver microsomes and the selective O-dealkylation of ethoxyresorufine by Cyt P450 1A1/ 1A2 provide an excellent means of selective monitoring of the carrier solution for the presence of compounds possessing affinity for Cyt P450 1A1/1A2. Eluting ligands (i.e., both inhibitors and substrates) competing with ethoxyresorufine for the active site of the Cyt P450s concerned cause a (temporarily) decreased production of resorufine that is monitored by fluorescence detection.
Cyt P450 enzyme affinity detection online coupled to HPLC
For operation of the Cyt P450 EAD system in HPLC mode ( Fig. 1B ), 2 pumps were used to control the HPLC gradient and, directly after the HPLC column, 2 pumps to compensate for increasing organic modifier concentrations before delivery of the eluent to the Cyt P450 EAD system. An Agilent 1100 series UV detector monitored the HPLC eluent at 220 nm, parallel to the fluorescent Cyt P450 EAD signal. HPLC separations were performed using a Phenomenex (Torrance, CA) 30-mm length × 2-mm i.d. stainless steel column (Luna 3µ C18(2)). The eluent from the HPLC was directed to a T-piece and split 1:9 with a flow splitter (5 cm length, 50 µm i.d., 375 µm o.d. and 5 cm length, 25 µm i.d., 375 µm o.d. fused silica connected to the T-piece) to the Cyt P450 EAD system and the UV detector, respectively.
For HPLC analysis, test compounds were dissolved in 30% MeOH in water. The HPLC column was eluted as follows: an initial flow rate of 1000 µL/min H 2 O/MeCN (95:5) for 2 min; then, a "decreasing flow rate" gradient of 12 min to 190 µL/min H 2 O/ MeCN (5:95) was performed, followed by 10 min at H 2 O/MeCN (5:95) with a flow rate of 190 µL/min. Finally, the column was equilibrated to the starting conditions in 0.5 min. To maintain a constant concentration of organic modifier in the Cyt P450 EAD system, another increasing flow rate gradient was mixed with the eluent from the column prior to the flow splitter. This compensatory gradient was as follows: an initial flow rate of 500 µL/min for 2 min at H 2 O/MeCN (3:1), an increasing flow rate gradient of 12 min to 1300 µL/min H 2 O/MeCN (100:0), and 10 min at H 2 O/ MeCN (1300:0) with a flow rate of 1300 µL/min. The H 2 O and the MeCN both contained 6% Tween-20. Reequilibration was performed in 0.5 min. The concentration of MeCN in the eluent after addition of the makeup gradient was 12% with a constant flow rate of 1500 µL/min. The initial high flow rate through the column, afforded by the decreasing flow rate gradient, ensures good resolution, combined with a constant Cyt P450 EAD-compatible organic modifier concentration of 12% after mixing of the decreasing flow rate gradient.
Microplate reader assay of Cyt P450 1A1/1A2 affinity
The microplate reader assay is based on O-dealkylation of ethoxyresorufine to the highly fluorescent resorufine by microsomal Cyt P450 1A1/1A2. 26 The fluorescence of resorufine was measured at λ ex 530 nm (bandwidth 8 nm) and λ em 580 nm (bandwidth 30 nm) on a Victor 2 1420 multilabel counter (Wallac, Turku, Finland).
Microplate reader assays were performed under 2 different conditions-namely, normal conditions and conditions used in the Cyt P450 EAD system-to determine possible differences in IC 50 s obtained. Concentration ranges of test compounds were prepared by serial dilution of compounds dissolved in DMSO (50 µL) with DMSO (150 µL). A mixture (150 µL) of rat liver microsomes (39.3 µg protein/mL) and ethoxyresorufine (150 nM) in 50 mM potassium phosphate buffer (pH 7.4), containing 2.5 mM MgCl 2 , was incubated for 15 min at 37°C. Then, one of the following solutions (75 µL) was added to start the reaction: (1) (normal condi- The carrier flow from the FIA system is replaced by a gradient reversed-phase high-performance liquid chromatography (HPLC) system. After HPLC, the makeup pumps produce a counteracting gradient, resulting in a P450 EAD-compatible constant organic modifier concentration. The eluent is then split 1:9 (90% to UV detection and 10% to P450 EAD). tions) a freshly prepared mixture of test compound in DMSO (20 µL) and 80 µL of a solution containing 50 µM NADPH in 12% MeCN or (2) (Cyt P450 EAD conditions) a freshly prepared mixture of test compound in DMSO (20 µL) and 80 µL of a solution containing 50 µM NADPH, 1 mg/mL PEG 6000, and 2 mg/mL Tween-20 in 12% MeCN. The increase in resorufin fluorescence was measured each minute over 6 min with the Victor 2 . The initial linear increase in resorufin fluorescence was a measure of the enzymatic activity. Inhibition curves based on 11 concentrations and a blank were measured in quadruplicate for each test compound. IC 50 values for each compound were determined with Prism3 software for both assay formats.
RESULTS AND DISCUSSION
Development and optimization of the Cyt P450 EAD system in flow injection analysis mode
Continuous mixing of enzyme (Cyt P450), a substrate (ethoxyresorufine), and the eluent from a carrier flow into a reaction coil is the basic concept of the new Cyt P450 EAD system, presented here. In the reaction coil, a continuous formation of fluorescent product takes place and is measured by a fluorescence detector at the end of the reaction coil. Eluting ligands temporarily inhibit fluorescent product formation, thus allowing detection of enzyme inhibition potential. The Cyt P450 EAD system developed was first tested by cooling the reaction coil to 0°C. This temperature decrease resulted in a reduced enzymatic activity, decreased product formation, and, hence, a lower baseline ( Fig. 2 ). After equilibration of the reaction coil to 37°C, resulting in a baseline rise to the original level, injections of the inhibitor α-NF (100.0 pmol) resulted in signals of 95% of the maximum signal, whereas blank injections showed no peaks at all. Injections of α-NF (100.0 pmol) in the system with the reaction coil cooled to 0°C gave no peaks (data not shown), indicating that the signals were due to α-NF and not caused by fluorescence quenching. The Cyt P450 EAD system was developed for the detection of Cyt P450 1A1/1A2 inhibitors in mixtures. Hence, the system was optimized both for assay sensitivity (signal-to-noise ratio) and for assay resolution (band broadening).
The influence of additives, substrate and enzyme concentration, reaction time, and temperature was first investigated in FIA Cyt P450 EAD mode to optimize the performance of the Cyt P450 EAD system. The influence of acetonitrile and methanol, to be used in HPLC mode, on the Cyt P450 EAD system performance was also tested in the FIA mode. All measurements were done in triplicate. Membrane-bound Cyt P450s and lipophilic compounds may adsorb to the wall of reaction coils, sometimes resulting in severe peak broadening. Several strategies were tested to reduce this phenomenon.
Additives. Different additives were tested to optimize resolution. Initially, the first superloop (SL-1, Fig. 1 ) contained β-NF-induced rat liver microsomes (39.3 µg protein/mL) in potas-sium phosphate buffer (50 mM, pH 7.4), containing 2.5 mM MgCl 2 . The second superloop (SL-2, Fig. 1 ) contained a solution of 40 µM NADPH, 300 nM ethoxyresorufine, and additive in potassium phosphate buffer (50 mM, pH 7.4), containing 2.5 mM MgCl 2 . Water was used as carrier solution. BSA, casein hydrolysate, glycine, glycerol, L-α-phosphatidylcholine dilauryl, and ELISA blocking reagent were tested as additives at different concentrations, but none improved the resolution when the inhibitor α-NF was injected at concentrations of 0.4 or 2 µM (data not shown). Similar experiments with additives were previously conducted by Oosterkamp et al., 15 who, in contrast, found that casein hydrolysate substantially reduced nonspecific binding of the estrogen receptor to the reaction coils and band broadening, resulting in higher resolution. Because this was not the case in the present experiments, it is suggested that the observed band broadening is mainly caused by the ligands and not the enzyme.
Several polymers were subsequently tested for their ability to improve resolution at concentrations of 0.4, 1, and 2 mg/mL in SL-2. Dextran resulted in significantly narrowed but also smaller peaks. Slightly smaller but significantly narrower peaks were obtained in the case of polyethylenimine at a concentration of 1 mg/ mL in SL-2. Equally good results in terms of resolution were obtained using PEG 6000 or PEG 3325. A concentration of 1 mg/mL PEG 6000 in SL-2 was found to be optimal and was therefore used further.
Various detergents (Tween-20 and Tween-80, sodium cholate, and saponin) added to the carrier solution were tested to increase resolution (final concentrations of 0.17, 0.33, 0.67, and 1.33 mg/ mL in the reaction coil for each detergent tested). All detergents tested significantly improved the resolution (data not shown). At detergent concentrations higher then 1.33 mg/mL, however, significant reductions in enzyme activity were seen. This is due to solubilization of microsomes. Saponin gave very irregular pump pressures. Sodium cholate resulted in increased baseline noise. Tween-20 and Tween-80 gave equally good results in terms of increased resolution. The resolution in terms of peak width (2-µM α-NF injections) decreased from 5.2 min when no detergents were used to 3.3 min when an optimal Tween-20 or Tween-80 concentration of 0.67 mg/mL was used.
Temperature. To evaluate temperature effects, ethoxyresorufine was not added to SL-2 but injected directly into the Cyt P450 EAD system. Water was used as carrier solution. Reaction coil temperatures of 15 to 60°C in steps of 5°C and 37°C were examined. The optimum temperature (yielding the highest resorufine signal upon 300-nM ethoxyresorufine injections) was found to be 37°C. This reaction coil temperature was subsequently used for further optimization.
Substrate, enzyme, coil volume, and organic modifiers.
To test the performance of the Cyt P450 EAD system with different concentrations of substrate, microsomes, reaction coil volume, MeOH, and MeCN, the inhibitor α-NF was injected in different amounts (i.e., 0, 18, 32, and 56 pmol). The results are shown in Figure 3A-E. The signal-to-noise (S/N) ratios were examined for each type optimization. Because the Cyt P450 EAD system does not give a linear but a sigmoidal response (in accordance with the enzymatic kinetics of Cyt P450), S/N ratios were chosen for optimization rather than peak areas. Similar strategies were previously followed in other online affinity detection methodologies. 16, 24 All concentrations used in the optimization process represent concentrations of the constituents in the reaction coil and not in the superloops (Fig. 1A) .
Substrate concentration. When varying the ethoxyresorufine concentration, optimal S/N ratios were obtained at a concentration of 150 nM. This ethoxyresorufine concentration was therefore used for further optimization.
Enzyme concentration. In the optimization of the microsomal protein concentration in the reaction coil ( Fig. 3B) , an optimum was found at a microsomal protein concentration of 19.7 µg protein/mL. Protein concentrations higher than 40 µg/mL were not tested because of the inherently increasing risk of clogging the Cyt P450 EAD system. Optimal S/N ratios were observed at a microsomal protein concentration of 19.7 µg protein/mL. This concentration was used for further optimization.
Coil volume. The S/N ratios obtained with different reaction coil volumes are shown in Figure 3C . Although larger coil volumes (i.e., longer reaction times) increased sensitivity in terms of S/N ratios, resolution was diminished. Similar effects have been seen with online estrogen receptor affinity detection screening by Oosterkamp et al. 15 With the present Cyt P450 EAD system, these effects are probably due to a combination of more product formation and more peak broadening (lower resolution) due to larger re-action coil volumes. Therefore, the smallest reaction coil volume (25 µL) was selected for further optimization.
Organic modifier concentration. Increasing the concentration of MeOH initially decreased the S/N ratios, probably due to enzyme destruction (Fig. 3D) . When the concentration of MeOH was further increased, however, an increase in the S/N ratio was seen. This observation was primarily due to increased resolution resulting in higher and sharper peaks. This effect was also described in Oosterkamp et al. 15 and is probably caused by reduced nonspecific binding of enzyme, ligands, and substrate. At even higher concentrations of organic modifier, this effect was less pronounced, and S/ N ratios decreased again, most likely due to enzyme denaturation. With MeCN, a similar effect was seen, except for the initial S/N ratios (Fig. 3E) . Although higher organic modifier concentrations will decrease enzymatic activity, a higher organic modifier concentration does allow more eluent from the HPLC column to flow into the Cyt P450 EAD system, resulting in higher sensitivity due to higher compound concentrations in the reaction coil. Finally, organic modifiers may increase resolution due to the creation of a more lipophilic environment, thus preventing lipophilic compounds and enzymes from adsorbing to the walls of the reaction coil. Reaction coil organic modifier concentrations of 3% to 6% MeOH and 1% to 3% MeCN were found to be optimal.
Reproducibility
Interday and intraday reproducibility were determined as follows: intraday variability was determined by injecting α-NF (25.0 pmol, eliciting 67% inhibition of the enzyme activity in the Cyt P450 EAD system) under optimized conditions, in triplicate, at 3.5-h time intervals. The intraday variability was examined without changing the content of the superloops. For interday reproducibility, α-NF (25.0 pmol) was injected daily in triplicate for 3 days with fresh solutions in the superloops each day. The optimized conditions consisted of β-NF-induced rat liver microsomes (59.1 µg protein/mL in SL-1, resulting in 19.7 µg protein/ mL in the reaction coil), potassium phosphate buffer (50 mM, pH 7.4, containing 2.5 mM MgCl 2 ) in SL-1 (100 µL/min), and NADPH (40 µM), ethoxyresorufine (450 nM in SL-2, resulting in 150 nM in the reaction coil), and 1 mg/mL PEG 6000 in the same buffer in SL-2 (100 µL/min). The carrier solution (100 µL/min) contained 12% MeCN with 2 mg/mL Tween-20. Intraday and interday reproducibility were both less than 3%, which is well within the range of bioanalytical screening methods. 16, 27 
Assay validation (FIA mode)
Microplate reader assay for Cyt P450 1A1/1A2 inhibition. For validation of the Cyt P450 EAD system, microplate reader-based assays were performed for comparison of the IC 50 values with those obtained with the Cyt P450 EAD system. All tested compounds showed sigmoidal concentration-response curves. The compounds were tested under 2 microplate reader conditions (setups 1 and 2)-namely, standard conditions (setup 1) and opti-
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mized conditions used in the Cyt P450 EAD system (setup 2) to determine possible differences in affinities. The IC 50 values obtained with the 2 different experimental conditions are presented in Table 1 and were found to be similar. Because similar results were obtained in setup 1 and setup 2, the conditions used in the Cyt P450 EAD system, which resemble the conditions of setup 2, are ex-pected to give the same results in terms of affinities as conditions normally used in Cyt P450 affinity screening (setup 1). Cyt P450 EAD system in FIA mode. The noise of the Cyt P450 EAD system was usually less than 3% of the maximal inhibition signal (Fig. 4) . The performance of the optimized Cyt P450 EAD system was ultimately evaluated with 7 known Cyt P450 1A1/1A2 ligands, and the data obtained were compared with the data from the microplate reader assay. To measure possible quenching of resorufine fluorescence by the ligands used, all ligands were also tested in the Cyt P450 EAD system, in which the substrate ethoxyresorufine was replaced by the product resorufine at concentrations similar to those formed during reaction in the optimized Cyt P450 EAD system. Blank carrier solution injections did not give a negative signal in the Cyt P450 EAD system. Injections of the inhibitory test compounds at high concentrations resulted in quenching of the fluorescence of resorufine in a number of cases (e.g., caffein, phenacetin, fluvoxamine, and β-NF injected at amounts of 4.0, 0.6, 0.5, and 0.2 µmol, respectively). The IC 50 curves for these compounds were therefore only determined at concentrations less than the lowest respective concentration at which quenching was observed.
For the Cyt P450 EAD assay, the total amount of inhibitory test compound injected was used to calculate the maximum concentration in the reaction coil. The dilution factor of the injected test compound to the final concentration in the reaction coil was determined first in the following way: known concentrations of resorufine (10 µM and 100 µM) were injected into the Cyt P450 EAD system, and the fluorescent peak heights were recorded. Next, the same concentrations of resorufine were infused via the carrier solution into the Cyt P450 EAD system. The increases in fluorescence after equilibration were compared to the peak heights of the injected resorufine samples. This was performed in triplicate. The peak heights obtained were 40% of the baselines obtained in the infusion experiments at both resorufine concentrations tested, indicating that the concentration of resorufine in the reaction coil was 13.3% of the injected concentration (40/3 = 13.3% due to the extra dilution factor of 3 in the reaction coil).
Each ligand tested was injected at different concentrations (prepared by serial dilution of 400-µL solutions in DMSO with 400-µL carrier solution) starting at a concentration eliciting 100% inhibition of the Cyt P450 EAD signal in FIA mode and ending at a concentration giving an S/N ratio of 3. A typical result for the inhibitor α-NF is shown in Figure 4 . The cumulative results for all 7 inhibitory test compounds are shown in Figure 5 . The correspondingly calculated IC 50 values are presented in Table 1 . The detection limit for each tested compound (S/N = 3) is also shown in Table 1 . For caffein and phenacetin, quenching of fluorescence at high concentrations prevented construction of complete IC 50 curves. For high-affinity inhibitors, such as α-NF, ellipticine, and 9-hydroxyellipticine, IC 50 values obtained with the Cyt P450 EAD system were well in accordance with those of the microplate reader assays. For low-affinity inhibitors (i.e., caffein and phenacetin), the inhibition curves could not be measured accurately with the Cyt P450 EAD system up to 100% inhibition; therefore, the comparison of the microplate reader assays and the Cyt P450 EAD system in those cases was less concordant, but estimates of the affinities could still be made.
Online coupling of the Cyt P450 EAD system to gradient HPLC
For online Cyt P450-based biochemical detection after HPLC separation, the Cyt P450 EAD system in FIA mode (Fig. 1A) was replaced by the Cyt P450 EAD system in HPLC mode (Fig. 1B) . Six inhibitory compounds were injected at 5 different concentrations and, after HPLC separation, detected with the Cyt P450 EAD system. IC 50 values were calculated in the same way as for the Cyt P450 EAD system in FIA mode. The IC 50 values of the test compounds of the Cyt P450 EAD system in HPLC mode are presented in Table 1 . The latter IC 50 values were well in agreement with those obtained with the Cyt P450 EAD system in FIA mode and the microplate reader assay results (setup 2) in the case of the high-affinity inhibitors. For the low-affinity inhibitors, the discrepancies seen are expected to result from the same cause as described in the previous section-namely, that the low-affinity inhibitors phenacetin and caffein showed fluorescence quenching when injected in the Cyt P450 EAD system in high concentrations, thus preventing complete IC 50 curves from being constructed accurately. However, the differences in IC 50 values obtained in the different measurement setups are within the acceptable range of microsomal P450 affinity measurements.
Representative superimposed chromatograms of different concentrations of the strong inhibitor α-NF and the weak inhibitor phenacetin are shown in Figure 6A and 6B, respectively. A representative chromatogram of a mixture of 6 test compounds is given in Figure 6C . Due to the sensitivity of the Cyt P450 EAD system, some baseline drift is observed during the gradient HPLC separations. The makeup HPLC gradient does not totally suppress the baseline drifting. When less HPLC eluent is flowing into the Cyt P450 EAD system, the baseline drift is significantly decreased, but so is the sensitivity. A B C peak broadening (or resolution) of compounds in the optimized Cyt P450 EAD system. Due to the nature of the Cyt P450 EAD system, in which compounds are subjected to an environment with a relatively low organic modifier concentration, it may be expected that compounds with a lipophilic character will have lower resolution, due to adsorption in the reaction coil, than hydrophilic compounds. To test this hypothesis, the σs for the injection port connected directly to the fluorescence detector (σ FLD ) and for the Cyt P450 EAD system eluting only with buffer (σ BUF ) were determined with resorufine injections (100 nM, triplicate injections). Finally, the σs of the Cyt P450 EAD system (σ TOT ) at test compound concentrations eliciting approximately 50% inhibition in the Cyt P450 EAD system were determined to calculate the σs of the respective test compounds (σ COM ). For calculation of the σs of the test compounds, the following formula was used:
).
The σ BUF was 0.12, and σ FLD was 0.08. The calculated σ COM s are presented in Table 1 . Compounds with more lipophilic character, as deduced from longer retention times on gradient HPLC ( Fig.  6C ) and lower solubility in aqueous environments, indeed had larger σs than the hydrophilic compounds.
CONCLUSIONS
The online coupling of a novel Cyt P450 EAD system to HPLC, as described in this study, enables for the first time Cyt P450 affinity screening of individual compounds in mixtures. Laborious preparative HPLC separation of compounds from mixtures, followed by microplate reader-based assays of the individual compounds, can be replaced by a single HPLC run coupled to online Cyt P450 EAD. The Cyt P450 EAD system in HPLC mode was able to separate a mixture of 6 ligands and subsequently detect them individually online as Cyt P450 1A1/1A2 inhibitors. Moreover, with the new Cyt P450 EAD system, both in FIA mode and in HPLC mode, IC 50 values of 7 known ligands were determined and were in accordance with traditional microplate reader assays. For high-affinity ligands of Cyt P450 1A1/1A2, detection limits of 1 to 3 pmol (n = 3; S/N = 3) were obtained. Different analytical parameters, such as substrate and enzyme concentration, reaction time, temperature, additives, and organic modifier concentration, were optimized for the Cyt P450 EAD system. The intraday and interday reproducibility (with an amount of α-NF eliciting 67% of maximal inhibition) were both less then 3% of the maximal inhibition signal. In contrast to previous online biochemical-based assays, in which soluble receptor (estrogen receptor 15 ), enzymes (phosphodiesterases 17 ), or antibodies (against cytokines or leukotrienes 18, 19 ) were used, measures were employed to prevent band broadening and to obtain stable baselines for longer time periods. The present HPLC-based postcolumn online Cyt P450 EAD system gave σs ranging between 0.31 min and 1.37 min for compounds eliciting 50% of the maximum inhibition measured with the Cyt P450 EAD system, which were about as good as σs seen in similar systems. [15] [16] [17] The σs of the compounds tested (at IC 50 concentration) indicate that more lipophilic compounds have larger σs. This may be due to adsorption of more lipophilic compounds in the reaction coil. More lipophilic compounds are also usually higher affinity inhibitors, which can also account for the larger σs found. In conclusion, the HPLC-based postcolumn online Cyt P450 EAD system is a valuable new tool to screen affinities of individual compounds in mixtures selectively and sensitively. This may be of great added value in drug discovery and toxicology.
